Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05310955
Other study ID # YSF2021-59
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 16, 2022
Est. completion date June 2023

Study information

Verified date August 2022
Source Shanghai Mental Health Center
Contact Anbei Lian
Phone 18117205070
Email 782115188@qq.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to observe the intervention effect of shen-based Qigong exercise on residual symptoms of schizophrenia.


Description:

Shen-based Qigong exercise is a new kind of health-care Qigong exercise based on the theory of traditional Chinese medicine, aiming at the characteristics of schizophrenia. In this study, a randomized controlled trial was conducted to observe the rehabilitation effect of this new exercise on residual symptoms of schizophrenic patients. Questionnaire, test and other experimental materials were used to evaluate the intervention effect of 12-week shen-based Qigong exercise on psychiatric symptoms, cognitive function, quality of life and social function of schizophrenic patients. At the same time, the related physical function and cardiac function indexes were used to evaluate the physical and cardiac rehabilitation effects of the exercise on patients from the aspects of "body" and "heart", so as to verify whether Qigong exercise has the effects of adjusting body and heart.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Han Chinese population 2. age = 18 years 3. education level = 6 years, can fill in the questionnaire independently, have enough audio-visual level to complete the necessary examination 4. assessed by MINI 7.0 and satisfied with the diagnostic criteria for schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fifth edition(DSM-5) 5. patients with schizophrenia residing in the rehabilitation ward, without relapse in the past 6 months 6. residual negative symptoms, with at least one item = 2 on the negative subscale of PANSS (N1-N7) 7. taking second generation antipsychotics 8. no training history of traditional Chinese exercises 9. agreement to participate in the study and willing to give written informed consent Exclusion Criteria: 1. having severe physical diseases such as cardiovascular, lung, liver, kidney, and hematopoietic diseases 2. satisfied with the diagnostic criteria for other mental disorders based on DSM-5 3. having alcohol or substance abuse/dependence 4. having mental retardation(WAIS<70) and/or severe cognitive impairment(MMSE<24) 5. having visual and / or hearing problems, unable to complete the relevant test 6. electroconvulsive or repetitive transcranial magnetic stimulation(rTMS) therapy in the past 3 months 7. currently enrolled or participated in other clinical studies in the past 3 months 8. participating in regular exercise training in the past 6 months 9. failure to sign or refuse to sign informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
daily rehabilitation interventions
including Naikan therapy, Morita therapy, group art therapy, group painting therapy
shen-based Qigong exercise
a 12-week intervention of shen-based Qigong exercise : exercise 5 days a week, about 30 minutes a day

Locations

Country Name City State
China Shanghai Mental Health Center Shanghai Shanghai

Sponsors (2)

Lead Sponsor Collaborator
Shanghai Mental Health Center Shanghai University of Traditional Chinese Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other change of n-back task Specific cognitive domain--working memory will be assessed by n-back task. N-back task paradigm is the most classical paradigm in working memory research. Change from Baseline at 3 months
Other change of 36-item Short Form Health Survey(SF-36) 36-item Short Form Health Survey(SF-36)will be used to assess the health-related quality of life of patients. SF-36 is one of the most commonly used standardized measurement tools for quality of life in the world, including eight subscales, a total of 36 items, involving physical and mental health. Change from Baseline at 3 months
Other change of Social-Adaptive Functioning Evaluation (SAFE) Social functions will be assessed using Social-Adaptive Functioning Evaluation (SAFE). SAFE can evaluate the social adaptation function of patients with mental disorders over 18 years old. It has a total of 19 items, divided into basic life skills, advanced life skills, social skills and communication skills in four areas; each item 0-4 score, the higher the score, the more serious the damage. Change from Baseline at 3 months
Other change of the Scale for the Assessment of Positive Symptoms (SAPS) Positive symptoms will be evaluated using the Scale for the Assessment of Positive Symptoms (SAPS). SAPS measures positive symptoms on a 34 item, 6-point scale, a total of 170 points. Items are listed under hallucinations, delusions, bizarre behavior, and positive formal thought disorder. Change from Baseline at 3 months
Other change of heart rate variability (HRV) Heart rate variability (HRV) will be used as the evaluation index for cardiac function. HRV is a widely used non-invasive tool for evaluating cardiac autonomic nerve function. Change from Baseline at 3 months
Other change of height Height will be measured using a height ruler, expressed in meters. Change from Baseline at 3 months
Other change of weight Weight will be measured using a weighting scale, expressed in kilograms. Change from Baseline at 3 months
Other change of waistline Waistline will be measured using a flexible rule, expressed in centimeters. Change from Baseline at 3 months
Other change of blood pressure Blood pressure will be measured using a sphygmomanometer, expressed in millimeter of mercury. Change from Baseline at 3 months
Other change of gait data Acquire gait data in a quiet, well-lit room. Specify the walking area to guide the participants to complete the walking cycle. Change from Baseline at 3 months
Primary change of the Scale for the Assessment of Negative Symptoms (SANS) Negative symptoms will be evaluated using the Scale for the Assessment of Negative Symptoms (SANS). The scale made up for the lack of attention to negative symptoms in previous psychiatric rating scales. It contains five subscales: affective blunting, alogia, avolition/apathy, anhedonia/asociality, and attention. A total of 24 items were scored at 6 levels for each item. Change from Baseline at 3 months
Secondary change of Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) RBANS will be used to assess global cognitive function. RBANS yields scaled scores for 5 cognitive domains and shows a good effect in cognitive assessment of patients with schizophrenia. Change from Baseline at 3 months
Secondary change of event-related potential P300 (ERP P300) ERP P300 will be used to assess global cognitive function. ERP P300 is an endogenous cognitive component related to high-level psychological activities such as attention, memory, feeling, learning and reasoning. It has good stability and can reflect the level of cognitive function from different aspects. Change from Baseline at 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A